Last reviewed · How we verify

NCT06628635

Examining Different Modes of Exercise for Acute Reduction in Blood Pressure

Completed NA Last updated 8 October 2024
What this trial tests

NA trial testing Exercise in Hypertension in 10 participants. Completed in 15 April 2024.

Timeline
4 January 2024
Primary endpoint
10 April 2024
15 April 2024

Quick facts

Lead sponsorUniversity of Saskatchewan
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposetreatment
Enrollment10
Start date4 January 2024
Primary completion10 April 2024
Estimated completion15 April 2024
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

University of Saskatchewan

Who can join

Eligibility, any sex, with Hypertension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the study is to compared different modes of exercise for eliciting post-exercise hypotension. The study will randomize 10 healthy participants to 30 minutes of either aerobic exercise, isometric exercise, stretching, or rest (control). Blood pressure and heart rate will be assessed before and for one hour post-exercise.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Stretching, isometrics, and aerobic exercise for decreasing blood pressure post-exercise: a randomized crossover study.
    Keller C, Chilibeck P. · · 2025 · cited 1× · PMID 39869856 · DOI 10.1139/apnm-2024-0439

Verify or expand the search:

Other trials of Exercise

Trials testing the same drug.

Other recruiting trials for Hypertension

Currently open trials in the same condition.

Other University of Saskatchewan trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06628635.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing